Cite
Elevated levels of serum urokinase plasminogen activator predict poor prognosis in hepatocellular carcinoma after resection
MLA
Kuo-Chin Chang, et al. “Elevated Levels of Serum Urokinase Plasminogen Activator Predict Poor Prognosis in Hepatocellular Carcinoma after Resection.” BMC Cancer, vol. 19, Dec. 2019. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....cad15bdf85fabcabb45c5d324453096e&authtype=sso&custid=ns315887.
APA
Kuo-Chin Chang, Chao-Hung Hung, Chien-Hung Chen, Tsung-Hui Hu, Ming-Chao Tsai, Yi-Hao Yen, & Ming-Tsung Lin. (2019). Elevated levels of serum urokinase plasminogen activator predict poor prognosis in hepatocellular carcinoma after resection. BMC Cancer, 19.
Chicago
Kuo-Chin Chang, Chao-Hung Hung, Chien-Hung Chen, Tsung-Hui Hu, Ming-Chao Tsai, Yi-Hao Yen, and Ming-Tsung Lin. 2019. “Elevated Levels of Serum Urokinase Plasminogen Activator Predict Poor Prognosis in Hepatocellular Carcinoma after Resection.” BMC Cancer 19 (December). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....cad15bdf85fabcabb45c5d324453096e&authtype=sso&custid=ns315887.